$44.00 -1.16 (%) GlaxoSmithKline Shs Sponsored American Deposit Receipt Repr 2 Shs - NYSE

Jan. 30, 2015 | 04:00 PM

Partner Headlines

  1. GlaxoSmithKline Expands Its Portfolio Of Medicines In The US For Patients With Asthma And COPD

    Benzinga | Jan. 26, 2015 | 09:21AM EST
  2. Benzinga's Weekend M&A Chatter

    Benzinga | Jan. 25, 2015 | 18:50PM EST
  3. Gilead Sciences Still has More Upside

    GuruFocus | Jan. 22, 2015 | 15:28PM EST
  4. Johnson & Johnson Riding High On Ebola Vaccines

    GuruFocus | Jan. 21, 2015 | 11:46AM EST
  5. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2

    Benzinga | Jan. 12, 2015 | 11:03AM EST
  6. Hot Biotech Stocks: Isis, Kite Jump On Big Deals

    IBD | Jan. 5, 2015 | 18:20PM EST
  7. Isis Pharma To Develop GI Drugs With J&J

    IBD | Jan. 5, 2015 | 13:17PM EST
  8. Pfizer, Home of Lipitor and Viagra, Lifts Dividend

    IBD | Dec. 31, 2014 | 17:16PM EST
  9. Ebola Drug Work Continues

    IBD | Dec. 26, 2014 | 18:22PM EST
  10. Viral Investing: Ebola Drug Makers' Varied Strategies

    IBD | Dec. 26, 2014 | 16:09PM EST
  11. BioMarin CEO Sees Big Future For Prosensa Drug

    IBD | Dec. 23, 2014 | 16:11PM EST
  12. Weekly 3-Year Low Highlights: RDS.B, GSK, WPZ, CLR

    GuruFocus | Dec. 14, 2014 | 21:52PM EST
  13. Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines

    Benzinga | Dec. 11, 2014 | 14:14PM EST
  14. Pfizer Spreading Its Wings Into A New Domain Of Life Sciences

    GuruFocus | Dec. 9, 2014 | 10:50AM EST
  15. Merck Bets $9.5 Billion On Cubist's War On Superbugs

    IBD | Dec. 8, 2014 | 18:49PM EST
  16. GlaxoSmithKline's Move A Testament That Pharma Companies Are Turning Focus Away From U.S.

    Benzinga | Dec. 1, 2014 | 11:58AM EST
  17. The Top 5 European Stocks Held During Q3

    GuruFocus | Nov. 25, 2014 | 18:19PM EST
  18. BioMarin buying Prosensa

    IBD | Nov. 24, 2014 | 18:43PM EST
  19. BioMarin Buying Prosensa, Backing Up Troubled Drug

    IBD | Nov. 24, 2014 | 10:22AM EST
  20. Screening Pharma Stocks Amid Turnaround

    YCharts | Nov. 19, 2014 | 09:37AM EST
  21. Jeff Auxier Buys Berkshire Hathaway in Third Quarter

    GuruFocus | Nov. 18, 2014 | 16:33PM EST
  22. Apollo may make Glaxo offer

    IBD | Nov. 13, 2014 | 18:37PM EST
  23. Irving Kahn Starts New Position In GlaxoSmithKline

    GuruFocus | Nov. 13, 2014 | 08:26AM EST
  24. Irving Kahn Buys Stake in GlaxoSmithKline During Q3 2014

    GuruFocus | Nov. 12, 2014 | 15:29PM EST
  25. Insys Q3 Beats Estimates, Helping Stock Rebound

    IBD | Nov. 11, 2014 | 11:33AM EST
  26. Kahn Brothers' Third Quarter Numbers

    GuruFocus | Nov. 7, 2014 | 17:43PM EST
  27. Ebola Vaccine Contenders

    Benzinga | Oct. 30, 2014 | 10:44AM EST
  28. Stock Futures Upshift On Data; Yahoo, Broadcom, Boeing Climb

    IBD | Oct. 22, 2014 | 09:01AM EST
  29. Benzinga Weekly Preview: Earnings Season Is In Full Swing

    Benzinga | Oct. 19, 2014 | 10:19AM EST
  30. Diamond Hill Capital Comments on GlaxoSmithKline PLC

    GuruFocus | Oct. 17, 2014 | 17:31PM EST
  31. Sarepta Therapeutics Shares Up On Ebola Drug Safety Study

    Benzinga | Oct. 17, 2014 | 10:58AM EST
  32. Hazmat Suit Maker Lakeland Soars On Dallas Ebola Fear

    IBD | Oct. 9, 2014 | 14:38PM EST
  33. Ebola-Related Pharma Stocks Soar On First U.S. Case

    IBD | Oct. 1, 2014 | 14:20PM EST
  34. Action Heats Up in Ebola-Related Equities

    FoxBusiness | Oct. 1, 2014 | 09:15AM EST
  35. Guru Stocks at 52-Week Lows: BHP, GSK, UTX, SAP, TEF

    GuruFocus | Sep. 30, 2014 | 13:10PM EST
  36. Pharma Stocks: Surprising Shift In U.S. Drug Market

    YCharts | Sep. 29, 2014 | 08:15AM EST
  37. Royal Bank of Scotland

    IBD | Sep. 25, 2014 | 18:53PM EST
  38. Gilead's New HIV Drug Key To Long-Term Strategy

    IBD | Sep. 24, 2014 | 17:29PM EST
  39. International Securities For A Diversified Income Portfolio

    GuruFocus | Sep. 23, 2014 | 13:36PM EST
  40. Could European Funds Offer An Opportunity Now?

    Benzinga | Sep. 23, 2014 | 10:04AM EST
  41. Widely Held Guru Stocks Trading In Europe

    GuruFocus | Sep. 22, 2014 | 17:56PM EST
  42. 3 Partnerships Pushing The Pharmaceutical Sector Forward

    Benzinga | Sep. 22, 2014 | 12:59PM EST
  43. Guru Stocks at 52-Week Lows: BHP, GSK, EC, VALE, ABB

    GuruFocus | Sep. 21, 2014 | 12:25PM EST
  44. China Fines Glaxo For Bribes

    IBD | Sep. 19, 2014 | 18:47PM EST
  45. Guru Stocks at 52-Week Lows: BHP, GSK, VOD, LYG, TEF

    GuruFocus | Sep. 16, 2014 | 12:27PM EST
  46. Stock Futures Down, But Not Far; Alibaba Sets IPO Price Range

    IBD | Sep. 8, 2014 | 09:07AM EST
  47. Benzinga's M&A Chatter for Wednesday August 27, 2014

    Benzinga | Aug. 27, 2014 | 20:45PM EST
  48. GSK Receives FDA Approval Of An Additional Promacta (eltrombopag) Indication For Use In Patients With Severe Aplastic Anaemia

    Benzinga | Aug. 26, 2014 | 15:56PM EST
  49. InterMune Stock Spikes On Rare Big Biotech Buyout

    IBD | Aug. 25, 2014 | 11:40AM EST
  50. 3 Dividend Kings From The U.K. I Love To Buy

    GuruFocus | Aug. 21, 2014 | 16:01PM EST
Trading Center